Stimulatory effect of GH3 cell line conditioned medium on the proliferation of the endothelial cell line (HECa10) in vitro

Neuroendocrinology Letters

Volumn 26, Issue 4, 2005, Pages 413-418

  Ławnicka, Hanna ^a   Kunert Radek, Jolanta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiogenesis; Endothelial cells; GH3 cells; Pituitary tumour cell culture; Tumour conditioned medium; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN GH3; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; IN VITRO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; PROTEIN SECRETION; TUMOR VASCULARIZATION;

EID: 27244447214     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Affara NI, Robertson FM. Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis. In Vivo. 2004; 18(5):525-42.
2. Akiba J, Yano H, Ogasawara S, Higaki K, Kojiro M. Expression and function of interleukin-8 in human hepatocellular carcinoma. Int J Oncol. 2001; 18(2):257-64.
3. Bancroft FC, Tashjian AH Jr. Growth in suspension culture of rat pituitary cells which produce growth hormone and prolactin. Exp Cell Res. 1971; 64(1):125-8.
4. Banerjee S, Saxena N, Sengupta K, Banerjee SK. 17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway.: Biochem Biophys Res Commun. 2003; 300(1): 209-15.
5. Banerjee SN, Sengupta K, Banerjee S, Saxena NK, Banerjee SK. 2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells. Neoplasia. 2003; 5(5):417-26.
6. Beck MT, Chen NY, Franek KJ, Chen WY. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer. Cancer Res. 2003; 63(13):3598-604.
7. Beerepoot LV, Mehra N, Linschoten F, Jorna AS, Lisman T, Verheul HM et al. Circulating endothelial cells in cancer patients do not express tissue factor. Cancer Lett. 2004;213(2):241-8.
8. Bizouarne N, Denis V, Legrand A, Monsigny M, Kieda C. A SV-40 immortalized murine endothelial cell line from peripheral lymph node high endothelium expresses a new α-L-fucose binding protein. Biol Cell. 1993; 79(3):209-218.
9. Boyd SR, Tan DS, de Souza L, Neale MH, Myatt NE, Alexander RA et al. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth. Br J Ophthalmol. 2002; 86(4):440-7.
10. Brien SE, Zagzag D, Brem S. Rapid in situ cellular kinetics of intracerebral tumor angiogenesis using a monoclonal antibody to bromodeoxyuridine. Neurosurgery. 1989; 25(5):715-9.
11. Brown CK, Khodarev NN, Yu J, Moo-Young T, Labay E, Darga TE et al. Glioblastoma cells block radiation-induced programmed cell death of endothelial cells. FEBS Lett. 2004; 565(1-3):167-70.
12. Castilla MA, Neria F, Renedo G, Pereira DS, Gonzalez-Pacheco FR, Jimenez S et al. Tumor-induced endothelial cell activation: role of vascular endothelial growth factor. Am J Physiol Cell Physiol. 2004, 286(5):C1170-6. Epub 2004 Jan 07.
13. Demeule M, Regina A, Annabi B, Bertrand Y, Bojanowski MW, Beliveau R. Brain endothelial cells as pharmacological targets in brain tumors. Mol Neurobiol. 2004; 30(2):157-83.
14. Denekamp J, Hobson B. Endothelial-cell proliferation in experimental tumours. Br J Cancer. 1982; 46(5):711-20.
15. Denekamp J. Endothelial cell proliferation as a novel approach to targeting tumour therapy. Br J Cancer. 1982; 45(1):136-9.
16. Erroi A, Bassetti M, Spada A, Giannattasio G. Microvasculature of human micro- and macroprolactinomas. A morphological study. Neuroendocrinology. 1986; 43(2):159-65.
17. Fagin JA, Pixley S, Slanina S, Ong J, Melmed S. Insulin-like growth factor I gene expression in GH3 rat pituitary cells: messenger ribonucleic acid content, immunocytochemistry, and secretion. Endocrinology. 1987; 120(5):2037-43.
18. Farnoud MR, Lissak B, Kujas M, Peillon F, Racadot J, Li JY. Specific alterations of the basement membrane and stroma antigens in human pituitary tumours in comparison with the normal anterior pituitary. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 1992; 421(6):449-55.
19. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18(1):4-25.
20. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161(2):851-8.
21. Folkman J, Long DM, Becker FF. Growth and metastasis of tumor in organ culture. Cancer 1963; 16:453-467.
22. Galfione M, Luo W, Kim J, Hawke D, Kobayashi R, Clapp C et al. Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr Purif 2003; 28(2): 252-8.
23. Giordano F, Mitola S. Characterization of endothelial cells isolated by human meningiomas. J Neurosurg Sci 2000; 44(4):177-85.
24. Gonzalez C, Corbacho AM, Eiserich JP, Garcia C, Lopez-Barrera F, Morales-Tlalpan V et al. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 2004; 145(12):5714-22.
25. Gorczyca W, Hardy J. Microadenomas of the human pituitary and their vascularization. Neurosurgery. 1988; 22(1 Pt 1):1 -6.
26. Hewett PW. Identification of tumour-induced changes in endothelial cell surface protein expression: an in vitro model. Int J Biochem Cell Biol 2001; 33(4):325-35.
27. Hobson B, Denekamp J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer 1984; 49(4):405-13.
28. Hunter JA, Skelly RH, Aylwin SJ, Geddes JF, Evanson J, Besser GM et al. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur J Endocrinol 2003; 148(2):203-11.
29. Ishikawa H, Heaney AP, Yu R, Horwitz GA, Melmed S. Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab 2001; 86(2):867-74.
30. Jabbour HN, Boddy SC, Lincoln GA. Pattern and localisation of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: expression is independent of hypothalamic control. Mol Cell Endocrinol 1997; 134(2):91-100.
31. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study. Endocr Pathol 1995; 6(2):115-124.
32. Komorowski J, Jankiewicz J, Stepien H. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours. Cytobios 2000; 101(398):151-9.
33. Kunkel P, Muller S, Schirmacher P, Stavrou D, Fillbrandt R, Westphal M et al. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. Neuro-oncol 2001; 3(2):82-8.
34. Lane BR, Liu J, Bock PJ, Schols D, Coffey MJ, Strieter RM et al. Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. J Virol. 2002; 76(22):11570-83.
35. Li A, Li H, Jin G, Xiu R. A proteomic study on cell cycle progression of endothelium exposed to tumor conditioned medium and the possible role of cyclin D1/E. Clin Hemorheol Microcirc 2003; 29(3-4):383-90.
36. Li A, Li H, Zhang J, Jin G, Xiu R. The mitogenic and anti-apoptotic activity of tumor conditioned medium on endothelium. Clin Hemorheol Microcirc 2003; 29(3-4):375-82.
37. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U et al. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 2001; 74(2):95-105.
38. Malaguarnera L, Imbesi RM, Scuto A, D'Amico F, Licata F, Messina A et al. Prolactin increases HO-1 expression and induces VEGF production in human macrophages. J Cell Biochem 2004; 93(1): 197-206.
39. Malaguarnera L, Pilastro MR, Quan S, Ghattas MH, Yang L, Mezentsev AV et al. Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human endothelial cells. Int J Mol Med 2002; 10(4):433-40.
40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65(1-2):55-63.
41. Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P et al. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology. 2003;37(3):674-85.
42. Parker BS, Argani P, Cook BP, Liangfeng H, Chartrand SD, Zhang M et al. Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res 2004; 64(21):7857-66.
43. Pawlikowski M, Grochal M, Kulig A, Zielinski K, Stepien H, Kunert-Radek J et al. The effect of angiotensin II receptor antagonists on diethylstilbestrol-induced vascular changes in the rat anterior pituitary gland: a quantitative evaluation. Histol Histopathol 1996; 11(4):909-13.
44. Pawlikowski M, Kunert-Radek J, Grochal M, Zielinski K, Kulig A. The effect of somatostatin analog octreotide on diethylstilbestrol-induced prolactin secretion, cell proliferation and vascular changes in the rat anterior pituitary gland. Histol Histopathol 1997; 12(4):991-4.
45. Pawlikowski M. Immunocytochemical prognostic markers in pituitary tumors. Folia Histochem Cytobiol 2001; 39(2):105-6.
46. Pepper MS. Positive and negative regulation of angiogenesis: from cell biology to the clinic. Vascular Medicine. 1996; 1(4):259-266.
47. Raccurt M, Lobie PE, Moudilou E, Garcia-Caballero T, Frappart L, Morel G et al. High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland. J Endocrinol 2002; 175(2):307-18.
48. Stepien H, Grochal M, Zielinski KW, Mucha S, Kunert-Radek J, Kulig A et al. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats. J Endocrinol 1996; 150(1):99-106.
49. Stepien HM, Kolomecki K, Pasieka Z, Komorowski J, Stepien T, Kuzdak K. Angiogenesis of endocrine gland tumours - new molecular targets in diagnostics and therapy. Eur J Endocrinol 2002;146(2):143-51.
50. Tashjian AH Jr, Yasumura Y, Levine L, Sato GH, Parker ML. Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 1968; 82(2):342-52.
51. Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2001; 2(11):667-73.
52. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. J Endocrinol 2000; 165(2):475-81.
53. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 2000; 85(3):1159-62.
54. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol. 1994; 144(6):1188-94.
55. Viacava P, Gasperi M, Acerbi G, Manetti L, Cecconi E, Bonadio AG et al. Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas. J Endocrinol Invest. 2003; 26(1):23-8.
56. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch. 2001; 438(6):595-602.
57. Vidal S, Lloyd RV, Moya L, Scheithauer BW, Kovacs K. Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary. J Histochem Cytochem. 2002; 50(4): 533-40.
58. Wang YK, Cui N, Li J, Luo B. Expression of pituitary tumor-transforming gene in endometrial carcinoma. Zhonghua Fu Chan Ke Za Zhi. 2004; 39(8):538-42.
59. Wilson SH, Davis MI, Caballero S, Grant MB. Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy. Growth Horm IGF Res 2001; 11 Suppl A: S53-9.
60. Wu QD, Wang JH, Condron C, Bouchier-Hayes D, Redmond HP. Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol 2001; 280(4):C814-22.